FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

8 results

deferasirox
(Deferasirox)
Teva Pharmaceuticals Inc
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients 10 and older, with specific liver iron and serum ferritin levels.
deferasirox
(DEFERASIROX)
Alembic Pharmaceuticals Limited
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients aged 2 years and older. The safety and efficacy of this drug with other iron chelation therapies are not established.
deferasirox
(deferasirox)
Bionpharma Inc.
Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for patients aged 10 and older with non-transfusion-dependent thalassemia syndromes who have specific liver iron levels and serum ferritin. Its safety with other iron chelation therapies is not established.
deferasirox
(Deferasirox)
Ascend Laboratories, LLC
Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.
deferasirox
(Deferasirox)
Actavis Pharma, Inc.
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron and serum ferritin levels.
deferasirox oral granules
(deferasirox)
EPIC PHARMA, LLC
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 years and older with specific iron levels.
deferasorox
(Deferasirox)
MSN LABORATORIES PRIVATE LIMITED
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration criteria. Safety with other iron chelation therapies is not established.
deferasorox
(Deferasirox)
Novadoz Pharmaceuticals LLC
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, as well as for those aged 10 and older with non-transfusion dependent thalassemia syndromes, if specific liver iron concentration and serum ferritin levels are met.

Medications for Hemochromatosis

deferasirox

deferasirox

deferasirox

deferasirox

deferasirox

deferasirox oral granules

deferasorox

deferasorox